GCM
COLL icon

Gallacher Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Gallacher Capital Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$481K Buy
+13,293
New +$454K 0.27% 114
2025
Q2 		– Sell
-8,713
Closed -$260K – 297
2025
Q1 		$260K Sell
8,713
-5,858
-40% -$179K 0.13% 214
2024
Q4 		$417K Buy
14,571
+470
+3% +$15.6K 0.21% 129
2024
Q3 		$545K Buy
14,101
+4,763
+51% +$170K 0.25% 89
2024
Q2 		$301K Buy
9,338
+3,582
+62% +$124K 0.16% 183
2024
Q1 		$223K Buy
+5,756
New +$201K 0.11% 229

Other funds holding COLL

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

Gallacher Capital Management's COLL Position: Q2 2026 in Review

Gallacher Capital Management opened a new position in Collegium Pharmaceutical (COLL) in Q2 2026: 13,293 shares worth $481K. The stake represents 0.27% of the portfolio and ranks #114 among its holdings. This is a return to the name: Gallacher Capital Management previously reported a position in COLL as recently as Q1 2025.

Gallacher Capital Management first reported a position in COLL in Q1 2024 and has held it in 6 quarters since. The position peaked at $545K in Q3 2024. 17 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Gallacher Capital Management held 13,293 shares of Collegium Pharmaceutical worth $481K as of Q2 2026.
  • Collegium Pharmaceutical was a new Gallacher Capital Management position in Q2 2026.
  • Collegium Pharmaceutical made up 0.27% of Gallacher Capital Management's portfolio in Q2 2026, its #114 holding.
  • Gallacher Capital Management first reported a position in Collegium Pharmaceutical in Q1 2024 and has held it in 6 quarters since.
  • Gallacher Capital Management's Collegium Pharmaceutical position peaked at $545K in Q3 2024.
  • 17 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Gallacher Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.